No CrossRef data available.
Published online by Cambridge University Press: 16 April 2020
Knowing the use profile of amisulpride, as well as information about its effectiveness and resistance in our environment.
Open and prospective study of a sample of 40 patients treated with amisulpride during their admission at hospital. We will note the following variables: age, sex, diagnosis, seriousness level in admission / discharge (measured through the BPRS scale), dose, concomitant medication, side effects, suspension reason, if any, and time at hospital.
We show the results of the studied variables, noticing the efficacy of the medicine in the symptomatological control of different disorders, specially schizophrenia. Furthermore, we have information about its resistance and about the medications, with what it is more frequently associated.
We can conclude, on the basis of the obtained results, that amisulpride is effective and well resisted in the greater part of the cases.
Comments
No Comments have been published for this article.